SANGAMO THERAPEUTICS, INC Earnings Per Share Diluted

Quick Answer

SANGAMO THERAPEUTICS, INC reported Earnings Per Share Diluted of $0.44 (loss) per share for the year ending 2025.

  • SANGAMO THERAPEUTICS, INC showed an increase of +10.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from SANGAMO THERAPEUTICS, INC's annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), SANGAMO THERAPEUTICS, INC's Earnings Per Share Diluted has grown by 48.2%.
  • Historical annual values: Fiscal year 2025: $0.44 (loss) per share | Fiscal year 2024: $0.49 (loss) per share | Fiscal year 2023: $1.48 (loss) per share | Fiscal year 2022: $1.25 (loss) per share | Fiscal year 2021: $1.23 (loss) per share | Fiscal year 2020: $0.90 (loss) per share | Fiscal year 2019: $0.85 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: